# DESCRIPTION

## ACKNOWLEDGEMENT OF GOVERNMENT SUPPORT

- acknowledge government funding

## BACKGROUND

- introduce pattern recognition receptors
- describe IFN synthesis and secretion
- discuss importance of IFN system
- highlight limitations of current STING agonists

## SUMMARY

- summarize STING pathway
- introduce disclosed small molecule and its effects

## DETAILED DESCRIPTION

### Terms

- define technical terms
- explain singular and plural referents
- clarify meaning of "or" and "and"
- describe approximate values for base sizes and molecular weights
- explain "include" and "comprise"
- define "consisting essentially of" and "consisting of"
- provide definitions for various terms

### Compounds:

- describe disclosed compounds and their formulas

### Pharmaceutical Compositions

- formulate pharmaceutical compositions
- describe additives and carriers
- outline methods of combining compound with carrier
- discuss controlled release formulations

### Treatment

- describe methods of treating alphavirus infection
- outline administration protocols and effective amounts

## EXAMPLES

### Example 1 Identification of a Novel IFN/IRF3-Inducing Molecule by High Throughput In Vitro Screening

- screen for small molecules inducing innate immune signaling

### Example 2—G10 Induces IFN/IRF3- but not NF-κB-Dependent Transcription in Human Fibroblasts

- confirm G10-induced IRF3-dependent transcription

### Example 3—G10 Elicits Antiviral Activity Against New and Old World Alphaviruses

- examine G10-mediated antiviral activity against various viruses

### Example 4—IRF3 is Essential to G10-Induced Transcription and Anti-Alphaviral Activity

- investigate IRF3 requirement for G10-induced effects

### Example 5—G10-Mediated IRF3 Activation and Anti-Alphaviral Activity Occur Independently of IPS-1/MAVS-Dependent Signaling

- examine IPS-1 independence of G10-induced IRF3 activation

### Example 6—STING is Required for G10-Mediated IRF3 Activation, Gene Expression, and Anti-Alphaviral Activity

- investigate STING requirement for G10-induced IRF3 activation
- examine STING requirement for G10-induced anti-Alphaviral activity

### Example 7—G10 Induces STING-Dependent Synthesis and Secretion of Bioactive Interferon

- examine G10-induced interferon synthesis and secretion

### Example 8—STAT1 is Required for G10-Mediated Anti-Alphaviral Activity and ISG Expression

- demonstrate STAT1 requirement

### Example 9—G10 Triggers IRF3-Dependent Activity with Less Potency than 2′3′-cGAMP

- compare G10 and 2′3′-cGAMP in IRF3 phosphorylation
- examine IRF3-dependent gene induction
- show G10 triggers IRF3 phosphorylation at 30 min
- show 2′3′-cGAMP elicits stronger mRNA synthesis
- illustrate transcriptional induction of IRF3- and IFN-dependent genes
- compare dose-dependent induction of IRF3-dependent genes
- show G10 induces innate antiviral mRNA expression in primary human cells
- examine transcription of IRF3-, IFN-, and NF-κB-dependent genes
- illustrate induction of NF-κB-dependent genes in primary human cells
- show G10 triggers expression of IRF3-dependent genes in primary human cells
- describe cell culture and virus preparation
- outline immunoblotting procedure
- detail RNA isolation and RT-PCR methods
- explain lentivector transduction and CRISPR/Cas9 genome editing
- describe luciferase reporter assays and protein purification
- outline in vivo administration of DMXAA and synthesis of G10 and analogs

